FENC
FENC
NASDAQ · Biotechnology

Fennec Pharmaceuticals Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks
$7.84
+0.18 (+2.35%)
As of Feb 8, 2:00 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +280.1% upside
Low Target $21.84
Average Target $29.80
High Target $37.23
Current Price $7.84
Current
$7.84
Target
$29.80
$21.84 $29.80 avg $37.23
Scenario Analysis
Bear Case
$21.84
178.6%
Low target
Base Case
$29.80
+280.1%
Avg target
Bull Case
$37.23
+374.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$28.64
-72.6% from high
52-Week Low
$19.99
+-60.8% from low
Target vs 52W High
$29.80
+4.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%